Interleukin 6 receptor (IL-6r) inhibition is a promising approach for the treatment of calcium pyrophosphate deposition disease (CPPD), although no prospective studies have been conducted to date.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results